Quality certified plant increases Avantor’s global pharmaceutical manufacturing base
Center Valley, PA (USA) – June 12, 2013 – Avantor™ Performance Materials, a global manufacturer and supplier of high-performance chemistries and materials, is now producing pharmaceutical chemicals under current Good Manufacturing Practices (cGMP) from its new production facility in Panoli, India.
The Panoli plant manufactures and packages a wide range of Avantor’s Macron Fine Chemicals™ brand of salts and solvents for the production of pharmaceuticals, and high-purity solvents for use in chromatography separations for laboratory research, drug development and discovery.
Located in India’s Gujarat state, the new Avantor facility is ISO 9001:2008 certified and is approved by the Indian Food and Drug Administration.
In addition to cGMP manufacturing requirements, Macron Fine Chemicals™ products from Panoli are produced to Indian Pharmacopeia (IP), United States Pharmacopeia (USP), National Formulary (NF), European Pharmacopeia (EP), Japanese Pharmacopeia (JP) and British Pharmacopeia (BP) standards.
“The availability of cGMP chemicals from our Panoli facility demonstrates Avantor’s continued growth as a leading global manufacturer and supplier of high-quality performance materials,” said Paul Smaltz, Avantor’s executive vice president of global pharmaceuticals.
“Our customers have said they desire a local source of raw materials that meet the global regulatory standards,” said Smaltz. “This facility is an important element in Avantor’s global strategy to provide our customers with what they need to have confidence in their pharmaceutical supply chain, no matter where they are located.”
Avantor obtained the facility as part of its acquisition of RFCL Limited (now known as Avantor Performance Materials India Limited) in 2011, when the plant was under construction. Production began in December 2012, with cGMP production commencing in January of 2013.
“The plant operates under Avantor’s globally accepted quality control systems and management of change processes,” said Smaltz. “This is one more example to show how Avantor is committed to complete regulatory documentation in order to help customers achieve better outcomes in their product development.”
Smaltz said the facility offers various pack sizes to support formulation development from discovery to full-scale production. He added that qualification samples of its cGMP products from the Panoli plant are available upon request.
Avantor’s Panoli plant expands the company’s global manufacturing footprint to seven major facilities throughout the world and increases the company’s capacity to serve pharmaceutical manufacturing customers as they pursue new market opportunities.
Visit www.avantormaterials.com or www.twitter.com/avantor_news for more information.
About Avantor™ Performance Materials
Based in Center Valley, PA (USA), Avantor Performance Materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the J.T.Baker®, Macron Fine Chemicals™, Rankem™, BeneSphera™, and POCH™ brands.
Avantor products are used in a wide range of industries. Our biomedical and life science solutions are used in academic, industry and quality control laboratories for research, pharmaceutical production and medical lab testing, while our electronics solutions are used in the manufacturing of semiconductors. For additional information please visit www.avantormaterials.com or follow www.twitter.com/avantor_news.
Vice President, Global Communications
Avantor Performance Materials, Inc.
Marketing Communications Manager
Avantor Performance Materials, Inc.